Discontinued — last reported Q2 '18
Other
Fair Value Measurement Disclosure
AbbVie Fair Value Measurement Disclosure remained flat by 0.0% to $24.65B in Q3 2025 compared to the prior quarter. Year-over-year, this metric grew by 12.4%, from $21.93B to $24.65B. Over 4 years (FY 2020 to FY 2024), Fair Value Measurement Disclosure shows an upward trend with a 13.4% CAGR.
Analysis
StatementBalance Sheet Statement
SectionOther
CategoryRisk
SignalContext dependent
VolatilityVolatile
First reportedQ3 2015
Last reportedQ2 2018
How to read this metric
Higher levels indicate a larger portion of the balance sheet is subject to market-based valuation volatility.
Detailed definition
This represents the aggregate carrying amount of assets and liabilities that are measured at fair value on a recurring o...
Peer comparison
Standard disclosure for financial institutions with significant investment holdings.
Metric ID:
fair_value_measurement_disclosureHistorical Data
18 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $14.99B | $14.92B | $267.00M | $13.82B | $15.18B | $14.56B | $163.00M | $17.93B | $19.15B | $18.67B | $66.00M | $20.16B | $21.15B | $21.93B | $313.00M | $22.71B | $24.65B | $24.65B |
| QoQ Change | — | -0.5% | -98.2% | >999% | +9.8% | -4.1% | -98.9% | >999% | +6.8% | -2.5% | -99.6% | >999% | +4.9% | +3.7% | -98.6% | >999% | +8.5% | +0.0% |
| YoY Change | — | — | — | — | +1.3% | -2.4% | -39.0% | +29.8% | +26.2% | +28.3% | -59.5% | +12.4% | +10.4% | +17.4% | +374.2% | +12.7% | +16.5% | +12.4% |
Range$66.00M – $24.65B
CAGR+12.4%
Avg YoY Growth+31.5%
Median YoY Growth+12.5%
Current Streak3 quarters growth
Fair Value Measurement Disclosure at Other Companies
Frequently Asked Questions
- What is AbbVie's fair value measurement disclosure?
- AbbVie (ABBV) reported fair value measurement disclosure of $24.65B in Q3 2025.
- How has AbbVie's fair value measurement disclosure changed year-over-year?
- AbbVie's fair value measurement disclosure increased by 12.4% year-over-year, from $21.93B to $24.65B.
- What is the long-term trend for AbbVie's fair value measurement disclosure?
- Over 4 years (2020 to 2024), AbbVie's fair value measurement disclosure has grown at a 13.4% compound annual growth rate (CAGR), from $189.00M to $313.00M.
- What does fair value measurement disclosure mean?
- The total value of assets and liabilities reported at current market prices.